Atlas Trials

Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Clinical trial NCT00006240 · COMPLETED

Trial details

NCT number
NCT00006240
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2000-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.